Skip to main content
Clinical Trials/NCT01276444
NCT01276444CompletedNot Applicable

Comparison of Goal-directed Algorithms of Hemodynamic Therapy After Combined Valve Repair: a Randomized Clinical Trial

Northern State Medical University1 site in 1 country43 target enrollmentStarted: January 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
43
Locations
1
Primary Endpoint
Mortality

Study Overview

Brief Summary

Valvular repair and repair surgery is rapidly progressing yet rather challenging aspect of current cardiosurgical practice.

Several approaches were introduced into the clinical practice to alleviate systemic inflammatory response induced by cardiopulmonary bypass and organ-specific injury including meticulous haemodynamic monitoring, pharmacological heart preconditioning, systemic use of anti-inflammatory agents, prevention of coagulopathy, and induced topical and systemic hypothermia. An in-depth monitoring of haemodynamics, oxygen transport, and vascular permeability is of a great clinical value to control the efficacy of these approaches.

Therefore, the aim of this study was to compare two algorithms of goal-directed therapy aimed to achieve a postoperative haemodynamic optimization in combined valve repair surgery.

Detailed Description

Forty-three adult patients scheduled for elective two valve replacement/repair were enrolled into randomised single-centre study. All interventions were performed in cardiosurgical department of City hospital #1 (Arkhangelsk, Russian Federation) by the same surgical team. Three patients were excluded from the analysis; two - due to protocol violation and one - due to inadequate surgical correction diagnosed by intraoperative transoesophageal echocardiography.

Day before surgery patients were asked for informed consent and randomized in two groups. In the first group postoperative haemodynamic optimization was targeted on parameters provided by pulmonary artery catheter (the PAC-group, n = 20): pulmonary arterial occlusion pressure, cardiac index (LifeScope monitor, Nihon Kohden, Japan) and hemoglobin blood level. In the second group haemodynamics was managed using parameters given by transpulmonary thermodilution (the COMPLEX-group), that included cardiac index, global end-diastolic volume index, extravascular lung water index, continuous central venous oxygen saturation, and oxygen delivery index as measured with PiCCO2 monitor (Pulsion Medical Systems, Munich, Germany. In addition, mean arterial pressure, heart rate, and hemoglobin concentration were included into both PAC- and PiCCO2-driven protocols.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Two valve repair / replacements
  • •Age above 18
  • •Informed consent

Exclusion Criteria

  • •pulmonary hypertension
  • •insulin-dependent diabetes mellitus
  • •severe atherosclerosis of femoral arteries
  • •severe respiratory failure
  • •pregnancy

Arms & Interventions

Pulmonary artery catheter (PAC)

Active Comparator

PAC was used to guide hemodynamic therapy after combined valve repair

Intervention: Swan-Ganz catheter (Device)

COMPLEX

Active Comparator

An combination of transpulmonary thermodilution and continuous monitoring of central venous saturation was used to guide hemodynamic therapy after combined valve repair surgery.

Intervention: transpulmonary thermodilution + central venous saturation (Device)

Outcomes

Primary Outcomes

Mortality

Time Frame: Day 28

Mortality rate at Day 28

Secondary Outcomes

  • Duration of respiratory support(Day 7)
  • Fit for discharge(non actual)
  • Vasoactive support(7 days)

Investigators

Sponsor
Northern State Medical University
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Comparison of Goal-directed Algorithms of... | Clinical Trial